Myeloma tumor cells were defined by expression of the plasma cell marker CD138 (CD138+), while CD138-negative (CD138–) cells defined the myeloma cell microenvironment, which is composed of osteoblasts and osteoclasts, as well as stromal, endothelial, and immune cells. This evidence concerns the gene SDC1 and neoplasm.